Labeled for this condition
Medicines for irritable bowel syndrome
7 medicines have an FDA label indicated for irritable bowel syndrome; 3 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for irritable bowel syndrome?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Dicyclomine | none listed | 43 labelers | $0.059 per tablet 20 mg tablet | No | No current entry | 3 |
| Lubiprostone | Amitiza, Amitza | 10 labelers | $0.651 per capsule 24 mcg capsule | No | No current entry | 3 |
| Chlordiazepoxide and clidinium | Librax | 12 labelers | $0.256 per capsule Chlordiazepoxide-clidinium capsule | Yes | No current entry | 2 |
| Rifaximin | Xifaxan | none listed | n/a | No | No current entry | 0 |
| Tenapanor | Xphozah, Ibsrela | none listed | $32.54 per tablet 50 mg tablet | No | No current entry | 0 |
| Linaclotide | Linzess | none listed | $9.02 per capsule 145 mcg capsule | Yes | No current entry | 1 |
| Eluxadoline | Viberzi | none listed | $28.09 per tablet 100 mg tablet | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price